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A facile and highly efficient one pot multi-component reaction for the synthesis of 2-thio-5-arylbenzo 
[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-one derivatives 4 under aqueous medium has been developed. The reaction takes place by 
condensation of thiobarbituric acids 1, 2-aminobenzothiazole 2 and aldehydes 3 using metal-proline catalyzed domino 
Knoevenagel, Michael and intramolecular cyclization approach. 
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Drugs and pharmaceuticals are mainly derived from 
heterocyclic compounds containing nitrogen and 
sulphur atoms. It has been found that incorporation of 
various fused heterocycles pyrimidine with nucleus 
enhances the biological activities. The structural 
diversity and biological importance of fused 
pyrimidines have made them attractive targets for 
synthesis over many years. Synthesis of heterocycles 
with a pyrimidopyrimidine or a thiazolopyrimidine 
framework is of particular importance as they exhibit a 
broad spectrum of biological properties and widely 
found for application in drug discovery. 
Pyrimidopyrimidines and its derivatives are important 
class of annulated uracils which have biological 
significance because of their connection with purine 
system
1







No generally useful 
procedures for the preparation of thiazolo[4,5-
d]pyrimidines have been reported. It has been briefly 
mentioned that the reaction of 4-amino-5-amidothiazoles 
with orthoformates in the presence of acetic anhydride 
leads to the desired thiazolo[4,5d]pyrimidines
5
. When 
carbodiimides which were derived from 
iminophosphoranes and aromatic isocyanates, were 
heated at temperatures slightly above their melting 




derivatives were also synthesized by the treatment of 2-
aminothiazole with the corresponding ketene S,S-
acetals
7
. The synthesis proceeded successfully in ethanol 
containing a catalytic amount of triethylamine. 
Pyrimidobenzothiazole derivative was also synthesized 
by reacting ketene S,S-acetal with 2-aminobenzothiazole 





utilized 6-amino-1,3-dimethyl uracils for the synthesis 
thiadiazolopyrimidines upon treatment with thionyl 
chloride-pyridine. 
We observe that it would be of interest to combine 
these two heterocyclic compounds – benzothiazolo 
pyrimidines and pyrimidopyrimidines – in a molecular 
framework. A survey of literature reveals that a very 
few work was done on the synthesis and biological 
activities of heterocyclic compounds containing 
benzothiazolopyrimidines fused with pyrimidine ring. 
Although various methods have been developed for the 
synthesis of thiazolo-pyrimidopyrimidines, most of 
these procedures offer several disadvantages, such as 
longer reaction times, unsatisfactory yields, drastic 
reaction conditions and use of costly or toxic catalysts. 
Multi-component reactions (MCRs) have been 
developed as an efficient and powerful tool in the 
synthetic organic chemistry for the synthesis of fused 
compounds in a one-pot reaction. These reactions 
enable the formation of compounds in an efficient 
way giving higher yields, saving time and energy, 
more economical and easier to isolate as compared to 
sequential synthesis of the same compound. 
Moreover, the synthesis of biologically active 
compounds in water, environmentally benign solvent, 
through multi-component reaction is one of the most 
widely developed methods
9-13
. It is planned to 
synthesize these heterocyclic compounds using 
dabco-based ionic liquids. Recently, we have reported 
the use of Dabco-based basic ionic liquids as highly 
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efficient and environmentally benign catalyst for the 
various organic reactions
14-16
. Due to their unique 
physiochemical properties, ionic liquids have become 
excellent candidates for a broad range of applications. 
Their solvation capacity towards a variety of 
materials, negligible vapour pressure, high thermal 
stabilities and wide liquid range indicate a great 
potential for replacement of volatile organic solvents. 
There are numbers of reports in which ionic liquids 
act as calalysts for chemical reactions. Most of these 
reactions are based on their possible use as “greener” 
alternatives to volatile organic solvents as well as 
their use to improve the reaction time, selectivity and 
yield of the products. 
Metal-mediated reactions in aqueous media have 
been found to be widely used in organic synthesis due 
to the environmentally benign conditions. Such 
organometallic type reactions in aqueous media have 
many advantages. The most general worth in changing 
organometallic reaction from strictly anhydrous 
organic solvents to aqueous media is the ease of 
reaction in obviating the need for inflammable 
anhydrous organic solvents and troublesome inert 
atmosphere. Furthermore, metal mediated reactions in 
aqueous media offer a number of advantages over 
conventional organometallic reaction in organic 
solvents: (i) there is the practical convenience, and 
possible environmental benefits, of not having to use 
inflammable and anhydrous organic solvents; (ii) the 
tedious task of protection deprotection chemistry for 
certain functional groups often encountered in organic 
synthesis may be obviated; (iii) water soluble 
‘compounds such as carbohydrates can be reacted 
directly without the need of derivatization; (iv) the 
regio- and stereochemical outcomes of the reactions 
may well change from organic to aqueous media and 
this offers new opportunities in synthesis. Thus metal-
mediated reactions in aqueous media have been found 
to have wide applications in organic synthesis not only 
in economic aspects but also from the environmental 
consideration Various metals have been found to be 
effective in mediating such a reaction. 
Our interest on the development of metal-proline 
complexes as organocatalysts for organic reactions in 
water medium and in continuation of our studies 
directed towards the synthesis of fused heterocycles
17-23
, 
prompted us to synthesis a new series of compounds 
containing benzothiazolopyrimidines fused with 
pyrimidine ring moiety. For the first time Darbre and 
Machuqueiro reported the Zn(proline)2 complex as 
highly enantioselective and competent catalyst for direct 
aldol reaction in aqueous media
24
 and further studies of 
Zn-proline complex was done by many researchers in 
the synthesis of Pyrazole
25
 and Pyrimidine derivative
26
 
in different solvents. 
In continuation of our ongoing studies on the 
synthesis of new variants of metal-proline complexes 
and to investigate the catalytic activities in water 
medium, here we report the use of metal-proline 
complexes for one-pot three component reactions for the 
syntheses of 2-thio-5-arylbenzo[4,5]thiazolopyrimi-
do[5,4-d]pyrimidin-4-one derivatives and the possibility 
of catalyst recycling. To the best of our knowledge, no 
reports have revealed the synthesis of these 
benzothiazolopyrimidines fused with pyrimidine ring 
moiety using metal-proline as catalyst in water. 
Results and Discussion 
Chemistry 
Metal-proline complexes were prepared by adding 
Et3N (0.7 mL) to a mixture of L-proline (5.0 mmol) in 
MeOH (10.0 mL); after 10 min, metal acetate 
(2.5 mmol) was added. After stirring for 45 minutes, a 
white precipitate was collected by filtration. 
Cd-proline complex gave the highest yield as 
compared to the other catalysts; the results are 
summarized in Table I. Complexes were characterized 
by NMR, IR, and ESI-MS. 
X-ray patterns of the prepared metal-proline 
complexes were recorded at 2Ɵ = 0-100 range and are 
shown in Figure 1. The crystalline size of the proline 
complexes of metals like Cd, Hg, and Pb were found to 
be 29.19, 28.41and 30.79 nm respectively, which were 
calculated by using Debye-Scherrer formula. The 
PXRD pattern of Pb-proline complex was matched 
with the data card 00-048-1161PDF2, the peaks 
revealed that the crystal was monoclinic in shape. 
The metal-proline complexes on excitation at λ 424 
nm gave two excitation wavelengths at 237 and 424 
Table I — Metal-proline complexes a 
Entry Catalyst (Metal-proline) Yield b (%) Time c (min)
1 Cd 96 48 
2 Zn 82 48 
3 Hg 73 52 
4 Pb 77 56 
a Reaction condition: metal-acetate (2.5 mmol), L-proline (5.0 
mmol), triethyl amine (0.7 mL) and methanol (10.0 mL) at room 
temperature. 
b Isolated yields. 
c Reaction progress monitored by TLC. 
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nm. The emission spectra were taken on λexc 424, at 
the range of 400-750 nm, Filter 450 and Slith Width 
of 2.5 found emission spectra at 607nm. The emission 
spectrum for Cd-proline complex was found 
unchanged after being recovered from the reaction 
medium. This shows that structure of the catalyst 
remain unchanged after the reaction. The results of 
UV and Fluorescence pattern of the prepared metal-
proline complexes are shown in Figure 2 and 
Figure 3, respectively. 
For preliminary investigation, selection for catalyst 
and reaction condition optimization was done with 
thiobarbituric acid 1a (1.0 mmol), 2-aminobenzothia-
zole 2 (1.0 mmol) and tolualdehyde 3a (1.0 mmol) in 
presence of the catalyst. Different catalysts and their 
effects on the reaction are tabulated (Table II). The 
reaction was found to be very fast and precipitate was 
formed as soon as the catalyst was added. For 
optimization of the reaction condition, first the reaction 
was stirred at room temperature and in refluxing 
condition without any catalyst to establish the 
efficiency of the catalyst, it was found that no desired 
product was obtained (Table II, entries 1 and 2). 
To optimize the reaction time and the amount of 
catalyst used, the reaction was carried out in the 
presence of different amount of catalysts (Table II). 
First, the effects of the concentration of catalyst for 
Zn-proline complex in different conditions were 
studied (Table II, entries 3-10). It was found that the 
use of zinc-proline catalyst (10 mol%) gave the 
product at 92% yield in 35 min at room temperature 
(Table II, entry 5). Similarly, the effects of the 
concentration of various catalysts in different 
conditions were also studied (Table II, entries 11-35). 
In all the cases, it was found that the concentration of 
catalysts were found to be good in 10 mol% at room 
temperature (Table II, entries 13, 21 and 30). Thus, 
from the results, 10 mol% of Zinc-proline catalyst at 
room temperature was used in presence of water for 
direct three component reactions for the ongoing 
research work. 
Catalytic activity and the reaction 
The effect of the concentration of catalyst for 
metal-proline complexes in different substrates were 
studied; mainly the concentrations of catalysts were 
found to be good in 10 mol%, and the results in effect 
on yields were shown in Figure 4. Thus we have 
selected the 10 mol% of catalyst for the reaction. 
Thus, encouraged by the results obtained from the 
optimization conditions,  the reactions  were further 
Figure 1 — PXRD pattern of metal-proline complexes 
Figure 2 — UV visible spectra of metal-proline complexes 
Figure 3 — Fluorescence Spectra of metal-proline complexes  
(λexc 247 nm) 
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conducted with different thiobarbituric acids using a 
wide range of aromatic aldehydes under similar 
conditions using 10 mol% of Zinc-proline complex as 
catalyst in aqueous medium as given in Table III. 
Experimental Section 
Melting points were determined with a Buchi 
Melting point M-560 apparatus and are uncorrected. 
IR Spectra were recorded in the solid state in the form 
Table II — Optimization of reaction condition using different catalysts for the synthesis of 2-thio-5-(4-methylphenyl)-


























Entry Catalyst (mol%) Temperature (°C) Time (min)b Yield of 4a (%)c 
1 No catalyst RTd 180 NPe 
2 No catalyst 100 180 NP 
3 Zinc-proline (2.0) RT 20 68 
4 Zinc-proline (5.0) RT 25 78 
5 Zinc-proline (10.0) RT 15 92 
6 Zinc-proline (15.0) RT 40 80 
7 Zinc-proline (2.0) 60 22 43 
8 Zinc-proline (5.0) 60 35 25 
9 Zinc-proline (10.0) 60 20 62 
10 Zinc-proline (15.0) 60 35 45 
11 Cadmium-proline (2.0) RT 30 45 
12 Cadmium-proline (5.0) RT 25 56 
13 Cadmium-proline (10.0) RT 20 75 
14 Cadmium-proline (15.0) RT 30 62 
15 Cadmium-proline (2.0) 60 30 35 
16 Cadmium-proline (5.0) 60 40 42 
17 Cadmium-proline (10.0) 60 30 48 
18 Cadmium-proline (15.0) 60 30 30 
19 Mercury-proline (2.0) RT 20 48 
20 Mercury-proline (5.0) RT 25 56 
21 Mercury -proline (10.0) RT 15 72 
22 Mercury-proline (15.0) RT 20 68 
23 Mercury-proline (2.0) 60 25 24 
24 Mercury -proline (5.0) 60 15 44 
25 Mercury-proline (10.0) 60 25 55 
26 Mercury -proline (15.0) 60 15 50 
28 Lead-proline (2.0) RT 20 45 
29 Lead-proline (5.0) RT 25 67 
30 Lead-proline (10.0) RT 15 82 
31 Lead-proline (15.0) RT 40 60 
32 Lead-proline (2.0) 60 22 20 
33 Lead-proline (5.0) 60 35 28 
34 Lead-proline (10.0) 60 20 54 
35 Lead-proline (15.0) 60 35 52 
a Reaction condition: metal-proline complex (10 mol%), thiobarbituric acid (1 mmol), 2-aminobenzothiazole (1 mmol) and tolualdehyde 
(1.0 mmol) in 5 mL water at room temperature; b Monitored by TLC; b Isolated yields; c Room temperature; d No desired product. 
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of KBr discs using a Shimadzu FT-IR 
spectrophotometer in the range of 200 cm
-1





H NMR spectra were recorded on Brucker–
ACF-400 (400 MHz) and 
13
C NMR spectra were 
recorded on Brucker–ACF-400 (100 MHz) in 
dimethylsulfoxide (DMSO-d6) and TMS as an internal 
standard. The FAB mass spectra were recorded at 
6000 Mass Spectrometer data systems using 
Argon/Xenon (6KV, 10mA) as the FAB gas. The 
CHN analyses were performed on Perkin-Elmer CHN 
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Figure 4 — Effect of concentration of catalyst on yield 
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analyzer. The accelerating voltage was 10 KV and the 
spectra were recorded at room temperature. All the 
commercial chemicals were distilled before use. 
 
Procedure for the synthesis of Metal-proline 
complexes 
Metal-proline complexes were prepared by adding 
Et3N (0.7 mL) to a mixture of L-proline (5.0 mmol) in 
MeOH (10.0 mL); after 10 min, metal acetate  
(2.5 mmol) was added. After stirring for 45 minutes, a 
white precipitate was collected by filtration. Complexes 
were characterized by NMR, IR, and ESI-MS. 
 
Zinc-proline complex: White amorphous solid; 
Yield=100%; m.p.= decomposed at 220°C; IR (KBr, 
Cm
-1
): 3217, 2962, 1605, 1447, 1335; 
1
H 
NMR(300MHz, D2O): 1.81 (m br, 3H), 2.22 (m br, 
1H), 2.96 (s br, 1H), 3.14 (m br, 1H), 3.82 (m br, 1H); 
13
CNMR (75 MHz, D2O): δ 24.9 (CH2-C), 31.4 (CH2-
NH), 47.2 (CH2-C), 59.8 (CH-CO); MS (D2O) m/z: 
291 [M]
+
; Anal Cald for C10H16ZnN2O4: C, 35.26; H, 
4.73; N, 8.22. Found: C, 35.19; H, 4.69; N, 8.20. 
 
Cadmium-proline complex: White amorphous 
solid; Yield=100%; m.p.= decomposed at 240°C; IR 
(KBr, Cm
-1
): 3269, 3202, 2964, 1575, 1389; 
1
H 
NMR(300MHz, D2O): δ1.66 (m, br, 3H), 2.12 (m, br, 
1H), 2.76 (s, br, 1H), 3.03 (m, br, 1H), 3.70 (m, br, 
1H); 
13
CNMR (75 MHz, D2O): δ 25.7(CH2-C), 
30.1(CH2-NH), 47.8 (CH2-C), 60.7(CH-CO);  
MS (D2O) m/z:358[M+H2O];Anal Cald for 
C10H16CdN2O4: C, 35.26; H, 4.73; N, 8.22. Found: C, 
35.19; H, 4.69; N, 8.20. 
 
Mercury-proline complex: White amorphous 





): 3543, 3231, 2974, 1615, 1424, 1070; 
1
H 
NMR (300MHz, D2O): δ1.56 (m, br, 3H), 1.96 (m, br, 
1H), 2.79 (m, br, 1H), 3.06 (s, br, 1H), 3.72 (m, br, 
1H);
 13
C NMR (75 MHz,D2O): δ 24.7(-CH2-C), 29.2(-
CH2-NH), 51.7(-CH2-C), 61.9(-CH-CO), 178.6(-CO); 
MS (D2O) m/z: 428[M
+
],429[M+H],447[M+H2O], 
467[M+K]; Anal Cald for C10H16HgN2O4: C, 28.01; 
H, 3.76; N, 6.53. Found: C, 27.95; H, 3.70; N, 6.48. 
 
Lead-proline complex: White amorphous solid; 





): 3236, 2981, 2868, 1653, 1571, 1377;
 
1
HNMR(300MHz,D2O): 1.93 (m, br, 3H), 2.23 (m, br, 
1H), 3.14(m, br, 1H), 3.23 (m, br, 1H), 3.91(m, br, 
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a Zinc-proline complex (10 mol%), thiobarbituric acid, 1 (1.0 mmol), 2-aminobenzothiazole, 2 (1.0 mmol) and aldehyde, 3 (1.0 mmol) in 
5.0 mL water at room temperature; b Isolated yield. 






CNMR (75 MHz, D2O): δ 178.3(-CO), 62.4 
(-CH-C), 49.1(-CH2-C), 47.1(-CH2-NH), 30.6(-CH2-
C); Anal Cald for C10H16N2O4Pb: C, 27.58, H, 3.70; 
N, 6.43. Found: C, 27.53, H, 3.62; N, 6.39. 
 
General procedure for the synthesis of 2-thio-5-aryl-
benzo[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-ones, 
4a-p 
Zinc-proline complex (0.1 mmol,10 mol%) was 
added to a mixture of aldehyde (1.0 mmol),  
2-aminobenzothiazole (1.0 mmol), and thiobarbituric 
acid (1.0 mmol) in 5.0 mL of water, then the reaction 
mixture was stirred at room temperature until the TLC 
indicate the complete reaction. After completion of the 
reaction, the organic part was removed by adding ethyl 
acetate and the aqueous phase was collected for further 
reaction. The organic part was washed once with water 
(10.0 mL), dried with anhydrous NaSO4 and then 
filtered. The crude mixture was concentrated on rotary 
evaporator under reduced pressure (Buchi Rotavapor) 
and was purified using flash chromatography. 
2-Thio-1,3-diphenyl-5-(4-methylphenyl)-benzo 
[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-one, 4a: 
Yellowish solid; anal. cal. for C31H22N4OS2: C, 70.17; 
H, 4.18; N, 10.56; S, 12.08%; found: C, 69.45; H, 
4.23; N, 10.16%. IR (KBr, cm
-1
): 1512, 1600, 1668, 
2924, 3032. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 
2.3 (3H, s, CH3) 5.2 (1H, s, CH), 7.1-8.3 (18H, m, Ar-
H), 
13
C-NMR (125 MHz, DMSO-d6, δ/ppm): 11.96, 
43.2, 124, 126, 128, 134, 165.8, 177.8. Mass (m/z): 
530.12 (100%), 531.13 (1.5%). 
2-Thio-1,3-diethyl-5-phenyl-benzo[4,5]thiazolop 
yrimido[5,4-d]pyrimidin-4-one, 4b: Yellowish solid; 
anal. cal. for C22H20N4OS2: C, 62.83; H, 4.79; N, 
13.32; S, 15.25%; found: C, 63.07; H, 5.04; N, 
13.61%. IR (KBr, cm
-1
): 1540, 1683, 2930, 3085. 
1
H-
NMR (500 MHz, DMSO-d6, δ/ppm): 0.8 (3H, t, CH3), 
1.2 (3H, t, CH3), 4.0 (2H, q, CH2), 4.2 (2H, q, CH2), 
5.1 (1H, s, CH), 7.2-7.4 (9H, m, Ar-H). 
13
C-NMR 
(125 MHz, DMSO-d6, δ/ppm): 11.62, 11.96, 43.21, 
43.87, 55.68, 63.16, 127.22, 129.16, 130.21, 132.91, 
151.46, 165.86, 176.48. Mass (m/z): 420.11 (100%), 
421.11 (1.6%). 
2-Thio-1,3-diethyl-5-(4-chlorophenyl)-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4c: Light 
yellow solid; anal. cal. for C22H19ClN4OS2: C, 58.08; 
H, 4.21; N, 12.31, S, 14.09%; found: C, 58.17; H, 
4.13; N, 12.11%. IR (KBr, cm
-1
): 1558, 1674, 2917, 
3040, 3067. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 
0.8 (3H, t, CH3), 1.2 (3H, t, CH3), 4.0 (2H, q, CH2), 
4.2 (2H, q, CH2), 5.3 (1H, s, CH), 7.1-7.4 (8H, m, Ar-
H). 
13
C-NMR (125 MHz, DMSO-d6, δ/ppm): 11.62, 
11.96, 43.21, 43.86, 56.34, 63.22, 128.34, 129.16, 
132.76, 151.4, 165.86, 177.91. Mass (m/z): 454.07 
(100%), 456.08 (2.7%). 
2-Thio-1,3-diethyl-5-(4-fluorophenyl)-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4d: White 
solid; anal. cal. for C22H19FN4OS2: C, 60.26; H, 4.37; 
N, 12.78; S, 14.62%; found: C, 60.11; H, 4.17; N, 
12.67%. IR (KBr, cm
-1
): 1407, 1669, 2907, 2910, 
3021. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 1.0 
(3H, t, CH3), 1.4 (3H, t, CH3), 4.1 (2H, q, CH2), 4.3 
(2H, q, CH2), 5.1 (1H, s, CH), 7.1-7.4 (8H, m, Ar-H). 
13
C-NMR (125 MHz, DMSO-d6, δ/ppm): 11.56, 
11.91, 43.50, 44.22, 51.02, 63.14, 127.21, 128.54, 
132.25, 166.08, 178.01. Mass (m/z): 438.10 (100%), 
439.10 (2.2%). 
2-Thio-1,3-diethyl-5-(4-bromophenyl)-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4e: Light 
yellow solid; anal. cal. for C22H19BrN4OS2: C, 52.91; 
H, 3.83; N, 11.22; S, 12.84%; found: C, 52.39; H, 4.02; 
N, 11.04%. IR (KBr, cm
-1
): 1413, 1566, 1661, 2916, 
2928, 3056. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 
1.1 (3H, t, CH3), 1.4 (3H, t, CH3), 4.0 (2H, q, CH2), 4.3 
(2H, q, CH2), 5.5 (1H, s, CH), 7.3-7.5 (8H, m, Ar-H). 
13
C-NMR (125 MHz, DMSO-d6, δ/ppm): 11.14, 11.66, 
43.21, 55.6, 128.63, 132.01, 165.76, 177.03. Mass 
(m/z): 498.02 (100%), 499.05 (1.4%). 
2-Thio-1,3-di(4-bromophenyl)-5-phenyl-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4f: Yellowish 
solid; anal. cal. for C30H18Br2N4OS2: C, 53.43; H, 2.69; 
N, 8.31; S, 9.51%; found: C, 53.49; H, 2.50; N, 8.17%. 
IR (KBr, cm
-1
): 1413, 1566, 1641, 2963, 3056. 
1
H-NMR 
(500 MHz, DMSO-d6, δ/ppm): 1.0 (3H, t, CH3), 1.2 (3H, 
t, CH3), 3.9 (2H, q, CH2), 4.1(2H, q, CH2), 5.2 (1H, s, 
CH), 6.8-7.8 (17H, m, Ar-H).
13
C-NMR (125 MHz, 
DMSO-d6, δ/ppm):11.9, 43.8, 63.2, 129.1, 131.4, 135.6, 
168.5, 178.4. Mass (m/z): 673.93 (100%). 
2-Thio-1,3-diethyl-5-(4-methoxyphenyl)-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4g: White 
solid; anal. cal. for C23H22N4O2S2: C, 61.31; H, 4.92; N, 
12.43; S, 14.23%; found C, 61.55; H, 4.58, N, 12.66%. 
IR (KBr, cm
-1
): 1402, 1554, 1639, 2964, 3066, 3109. 
1
H-
NMR (500 MHz, DMSO-d6, δ/ppm): 0.8 (3H, t, CH3), 
1.2 (3H, t, CH3), 3.8 (3H, s, OCH3), 4.1 (2H, q, CH2), 
4.2 (2H, q, CH2), 5.0 (1H, s, CH), 7.2-7.7 (8H, m, Ar-
H). 
13
C-NMR (125 MHz, DMSO-d6, δ/ppm): 11.6, 
43.2, 55.2, 121.2, 129.2, 138.3, 167.5, 176.5. Mass 
(m/z): 450.12 (100%), 451.15 (1.5%). 
2-Thio-1,3-diethyl-5-(4-methylphenyl)-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4h: Pale 




yellow solid; anal. cal. for C23H22N4OS2: C, 63.57; H, 
5.10; N, 12.89; S, 14.75%. found C, 64.07; H, 4.98; 
N, 13.04%. IR (KBr, cm
-1
): 1414, 1543, 1665, 2972, 
3040, 3101. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 
0.8-1.0 (6H, t, 2CH3), 1.5 (3H, s, CH3), 3.9-4.2 (4H, 
q, 2CH2), 5.1 (1H, s, CH), 7.1-7.5 (8H, m, Ar-H).
13
C-
NMR (125 MHz, DMSO-d6, δ/ppm): 11.4, 12.0, 18.7, 
43.2, 45.6, 56.8, 127.2, 133.4, 136.2, 168.2, 177.8. 
Mass (m/z): 434.12 (100%), 435.13 (1.5%). 
2-Thio-1,3-di(4-bromophenyl)-5-(4-methylphenyl)-
benzo[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-one, 4i: 
White solid; anal. cal. for C31H20N4OS2: C, 54.08; H, 
2.93; N, 8.14; S, 9.31%. found C, 54.19; H, 2.27; N, 
8.35%. IR (KBr, cm
-1
): 1410, 1575, 1677, 2919, 3049, 
3104. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 1.2-1.5 
(6H, t, 2CH3), 2.1 (3H, s, CH3), 4.3-4.5 (4H, q, 2CH2), 
4.8 (1H, s, CH), 6.3-7.8 (16H, m, Ar-H). 
13
C-NMR 
(125 MHz, DMSO-d6, δ/ppm): 11.8, 12.03, 18.3, 43.7, 
44.1, 57.2, 127.2, 136.6, 166.7, 178.5. Mass (m/z): 
687.94 (100%), 688.94 (1.3%). 
2-Thio-1,3-di(4-methylphenyl)-5-phenyl-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4j: Light 
Yellow solid; anal. cal. for C32H24N4OS2: C, 70.56; H, 
4.44; N, 10.29; S, 11.77%. found C, 70.23; H, 4.42; 
N, 10.45%.IR (KBr, cm
-1
): 1413, 1572, 1681, 2917, 
3004, 3061.
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 
1.98 (3H,s, CH3), 2.13(3H, s, CH3), 5.4 (1H, s, CH), 
6.7-7.8 (17H, m, Ar-H). 
13
C-NMR (125 MHz, 
DMSO-d6, δ/ppm):20.6, 21.2, 55.6, 129.4, 130.5, 
131.4, 135.8, 168.8, 176.4. Mass (m/z): 544.14 
(100%), 545.14 (1.5%). 
2-Thio-1,3-di(4-chlorophenyl)-5-phenyl-benzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one, 4k: Yellow 
solid; anal. cal. for C30H18Cl2N4OS2: C, 61.54; H, 3.10; 
N, 9.57; S, 10.95%. found C, 61.55; H, 3.48; N, 9.51%. 
IR (KBr, cm
-1
): 1480, 1589, 1686, 2924, 3012. 
1
H-NMR 
(500 MHz, DMSO-d6, δ/ppm): 5.2 (1H, s, CH), 6.6-7.8 
(17H, m, Ar-H). 
13
C-NMR (125 MHz, DMSO-d6, 
δ/ppm): 55.4, 123.6, 129.1, 131.4, 137.2, 166.4, 178.2. 
Mass (m/z): 584.03 (100%), 585.03 (1.1%). 
2-Thio-1,3-di(4-chlorophenyl)-5-(4-methylphenyl)-
benzo[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-one, 
4l: Pale yellowish solid; anal. cal. for C31H20Cl2N4OS2: 
C, 62.10; H, 3.36; N, 9.35; S, 10.69%. Found C, 
62.03; H, 3.80; N, 9.22%.IR (KBr, cm
-1
): 1472,1599, 
1720, 3309, 3113. 
1
H-NMR (500 MHz, DMSO-d6, 
δ/ppm): 2.3(3H, s, CH3), 5.2 (1H, s, CH), 7.2-7.8 
(16H, m, Ar-H).
13
C-NMR (125 MHz, DMSO-d6, 
δ/ppm: 23.2, 56.4, 128.2, 129.3, 129.6, 134.2, 166.8, 
176.2. Mass (m/z): 598.05 (100%), 599.04 (1.6%). 
2-Thio-1,3-di(4-chlorophenyl)-5-(4-methoxyphenyl) 
-benzo[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-one, 
4m: White solid; anal. cal. for C31H20Cl2N4O2S2: C, 
60.49; H, 3.28; N, 9.10; S, 10.42%. found C, 60.88; 
H, 3.12; N, 9.27%. IR (KBr, cm
-1
): 1485, 1681, 2976, 
3045. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 3.9 
(3H, s, OCH3), 5.6 (1H, s, CH), 7.2-7.8(16H, m, Ar-
H). 
13
C-NMR (125 MHz, DMSO-d6, δ/ppm): 43.8, 
56.2, 128.2, 129.4, 138.1, 167.8, 180.2. Mass (m/z): 
614.04 (100%), 615.04 (1.0%). 
2-Thio-1,3-di(2-nitrophenyl)-5-(4-chlorophenyl)-
benzo[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-one, 
4n: Yellowish solid; anal. cal. for C30H17ClN6O5S2: C, 
56.21; H, 2.67; N, 13.11; S, 10.00%. found C, 56.01; 
H, 2.72; N, 13.47% . IR (KBr, cm
-1
): 1433, 1682, 
2970, 3013. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 
5.2 (1H, s, CH), 7.1-7.6 (16H, m, Ar-H). 
13
C-NMR 
(125 MHz, DMSO-d6, δ/ppm: 55.2, 127.6, 128.2, 
132.1, 136.1, 167.8, 177.8. Mass (m/z): 640.04 
(100%), 641.04 (1.5%). 
2-Thio-1,3-di(4-methylphenyl)-5-(4-methylphenyl) 
-benzo[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-one, 
4o: Light yellowish solid; anal. cal. for C33H26N4OS2: C, 
70.94; H, 4.69; N, 10.03; S, 11.48% Found C, 70.81; H, 
4.52; N, 10.18%. IR (KBr, cm
-1
): 1512, 1678, 2967, 
3044. 
1
H-NMR (500 MHz, DMSO-d6, δ/ppm): 2.32 
(9H, s, 3CH3) 5.8 (1H, s, CH), 6.8-7.7 (16H, m, Ar-H). 
13
C-NMR (125 MHz, DMSO-d6, δ/ppm: 23.2, 55.1, 
128.3, 129.2, 132.1, 137.1, 166.8, 174.6. Mass (m/z): 
558.15 (100%), 559.15 (2.7%). 
2-Thio-1,3-di(2-methylphenyl)-5-(4-methoxyp 
henyl)-benzo[4,5]thiazolopyrimido[5,4-d]pyrimidin-4-
one, 4p: Reddish yellow solid; anal. cal. for 
C33H26N4O2S2: C, 68.97; H, 4.56; N, 9.75; S, 11.16% 
Found C, 68.56; H, 4.81; N, 11.23%. IR (KBr, cm
-
1
):1512, 1668, 2924, 3032, 3119. 
1
H-NMR (500 MHz, 
DMSO-d6, δ/ppm): 2.3 (6H, s, 2CH3), 3.8 (3H, s, 
OCH3), 5.1 (1H, s, CH), 6.7-7.8 (16H, m, Ar-H),8.2 
(2H, s, 2NH), 
13
C-NMR (125 MHz, DMSO-d6, 
δ/ppm: 23.1, 43.8, 55.6, 128.6, 129.4, 136.7, 167.8, 
174.6. Mass (m/z): 574.15 (100%), 575.15 (1.6%). 
 
Conclusion 
The synthesis of 2-thio-5-arylbenzo[4,5] 
thiazolopyrimido[5,4-d]pyrimidin-4-one derivatives (4) 
under aqueous medium by condensation of 
thiobarbituric acids (1), 2-aminobenzothiazole (2) and 
aldehydes (3) using metal-proline as catalyst has been 
developed. The yields were found to be high and the 
reaction takes place by domino Knoevenagel, Michael 




and intramolecular cyclization approach which is found 
to be simple and environment friendly. 
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